Insider Shareholders with Direct Ownership of Nex Immune, Inc. (NEXI)
This section provides a comprehensive overview of the insiders with direct ownership of Nex Immune, Inc. (NEXI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NexImmune, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 1,650,182 | 0 | 2,217,814 $842,769 | 12 |
Mar 30, 2023
Added 15.28%
|
|
| 1,105,495 | 0 | 1,105,495 $420,088 | 10 |
Jun 07, 2022
Added 2.37%
|
|
|
John Trainer
Chief Financial Officer |
142,360 | 0 | 186,969 $71,048 | 6 |
Nov 22, 2022
Added 40.11%
|
|
Mathias Oelke
Chief Science Officer |
126,100 | 0 | 134,023 $50,928 | 1 |
Nov 22, 2022
Added 48.48%
|
| 71,749 | 0 | 78,199 $29,715 | 1 |
Feb 17, 2021
Added 17.37%
|
|
| 27,847 | 0 | 27,847 $10,581 | 1 |
Feb 17, 2021
Added 12.86%
|
|
|
Scott Carmer
President and CEO |
7,058 | 0 | 7,058 $2,682 | 1 |
Feb 17, 2021
Added 50.0%
|
|
Jerome B Zeldis
Executive VP of Research & Dev |
5,882 | 0 | 5,882 $2,235 | 1 |
Feb 17, 2021
Added 50.0%
|
|
Kristi Jones
President and CEO |
322,350 | 0 | 1 $0 | 4 |
Jun 11, 2024
Added 50.0%
|
|
Alan S. Roemer
Director |
195,641 | 7,825 | 0 $0 | 4 |
Nov 22, 2023
Reduced 100.0%
|